Pfizer Starna Licensing Agreement: Pfizer Secures Exclusive In Vivo CAR-T Rights for Autoimmune Diseases in $330 Million Upfront Deal

pfizer news

The Pfizer Starna licensing agreement hands Pfizer exclusive rights outside Greater China to three pre-IND in vivo CAR-T autoimmune programs, backed by a $330 million upfront payment and up to $2.3 billion in milestones.